Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute

First patient ever treated with Alpha DaRT for pancreatic cancer in Italy, under a clinical study conducted at the world-renowned Pancreas ...
Nasdaq

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

JERUSALEM, April 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that the FDA has ...
Yahoo Finance

HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT

TOKYO, February 25, 2026--(BUSINESS WIRE)--HekaBio K.K., (Headquarters: Chuo-ku, Tokyo) announces that the innovative solid tumor treatment device ‘Alpha DaRT (Diffusing Alpha Radiation Therapy),’ ...
Hackaday

alpha radiation

In the middle of the 20th century, the atom was all the rage. Radiation was the shiny new solution to everything while being similarly poorly understood by the general public and a great deal of those ...
FierceBiotech

Alpha Tau hops aboard the SPAC train with $367M deal to take its tumor-blasting tech public

Armed with a recent breakthrough designation from the FDA for its tumor-destroying radiation technology, Alpha Tau Medical is plowing ahead with plans to go public before the end of the year. To do so ...